Helsinn
Helsinn is a subsidiary of global pharmaceutical company Helsinn.
Helsinn is a privately owned, self-financing pharmaceutical group with headquarters in Lugano, Switzerland and premises in Ireland and USA. The Helsinn Group has been built on the basis of a unique business model, focused on the in- and out-licensing of pharmaceuticals, with the recent additions of medical devices in therapeutic niche areas.
Financial Data
-
31st Dec 20 Source: CRO
- €138.6 million turnover
-
-€1.5 million
profit - 197 employees
-
31st Dec 19 Source: CRO
- €121.1 million turnover
-
-€17.6 million
profit - 186 employees
- 9 more years available »
Ranking
By Turnover
(€138.6 million)- 405th in Top Companies
- 41st in Pharma
By Employees
(197)- 607th in Top Companies
- 56th in Pharma
-
- 197
- €138.6 million
Employees
- Giorgio Calderari CEO/Managing Director
Latest News
- May 21 Consumer giant Procter & Gamble sells last Irish manufacturing plant
- May 21 Nama clashes with Fingal council over lands with space for up to 7,000 new homes
- May 20 Attempt by investors to appoint inspector to firm ‘without precedent’, court hears
- May 20 Amarenco and SSE among groups to win green Eirgrid contracts
- May 20 Cerberus collected €113m last year from Irish loans it bought after the 2008 crash